A singled-blinded randomized controlled trial (RCT), pretest-posttest design technique was used to examine the effectiveness of the phone-based support program (PBSP) among women newly diagnosed with breast cancer undergoing chemotherapy. breast cancer self-care self-efficacy psychological well-being and quality of life
Conditions
Interventions
Sponsors
None listed
Eligibility
Inclusion criteria
Inclusion criteria: The participants will be recruited through the target population. The inclusion criteria will be:(1) at least 18 years of age, (2) newly diagnosed as breast cancer with non-metastatic or stage II or lower within the past 3-8 weeks, (3) treated with chemotherapy after surgery at the study sites, (4) be able to access the internet with a mobile phone (5) be contactable via the mobile phone for follow up; and (6) able to communicate Mandarin.
Exclusion criteria
Exclusion criteria: The exclusion criteria will be: (1) having a concurrent major physical illness, like any physical surgery except for the surgery treatment for breast cancer, injuries or illnesses with the potential for lifelong disability, advanced chronic illness, profound coma, permanent paralysis, or severe brain injury (2) having a chronic mental health problem as diagnoses by a psychiatrist, and (3) unable to complete all session of the implementation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The Self-Care Self-Efficacy 3 time points of before the patient's intervention (T1, week 0), after completed the intervention week 3(T2), and at follow-up (T3, week7) The Self-Care Self-Efficacy Scale | — |
Secondary
| Measure | Time frame |
|---|---|
| psychological well-being 3 time points of before the patient's intervention (T1, week 0), after completed the intervention week 3(T2), and at follow-up (T3, week7) The M.D. Anderson Symptom Inventory The Hospital Anxiety and Depression Scale (HADS),quality of life 3 time points of before the patient's intervention (T1, week 0), after completed the intervention week 3(T2), and at follow-up (T3, week7) European Organization for Research and Treatment of Cancer QOL | — |
Countries
China
Contacts
Jiangsu commission of Health